Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China
BackgroundIdentifying individuals at high risk of atherosclerotic cardiovascular disease (ASCVD) and implementing targeted prevention strategies might be the key to reducing the heavy disease burden in China. This study aimed to evaluate the prevalence, awareness, treatment, and risk factor control...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-07-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1092058/full |
| _version_ | 1827900872790638592 |
|---|---|
| author | Hui Liu Weiquan Lin Weiquan Lin Kexin Tu Qin Zhou Qin Zhou Chang Wang Minying Sun Minying Sun Yaohui Li Xiangyi Liu Guozhen Lin Sidong Li Wei Bao |
| author_facet | Hui Liu Weiquan Lin Weiquan Lin Kexin Tu Qin Zhou Qin Zhou Chang Wang Minying Sun Minying Sun Yaohui Li Xiangyi Liu Guozhen Lin Sidong Li Wei Bao |
| author_sort | Hui Liu |
| collection | DOAJ |
| description | BackgroundIdentifying individuals at high risk of atherosclerotic cardiovascular disease (ASCVD) and implementing targeted prevention strategies might be the key to reducing the heavy disease burden in China. This study aimed to evaluate the prevalence, awareness, treatment, and risk factor control among individuals with high 10-year ASCVD risk in Guangzhou, China.MethodsThis study included 15,165 adults (aged 18 years and older) from 138 urban and rural communities in the 2018 survey of China Chronic Disease and Risk Factors Surveillance in Guangzhou. 10-year ASCVD risk was estimated using the risk assessment models recommended in the Chinese Guideline for the Prevention of Cardiovascular Disease 2017. The prevalence, awareness, treatment, and risk factor control of high ASCVD risk (defined as 10-year risk ≥10%) were examined.ResultsAmong the study population, the weighted proportion of men was 51.9%, and the mean age was 41.27 ± 0.52 years. The overall standardized prevalence of high 10-year ASCVD risk was 13.8% (95% CI, 12.4%–15.3%). The awareness rates for hypertension, diabetes, and hyperlipidemia were 48.0% (95% CI, 42.8%–53.4%), 48.3% (95% CI, 43.0%–53.7%), and 17.9% (95% CI, 14.4%–22.1%) among those with corresponding risk factors. The proportions of drug use in prevention were relatively low in primary prevention, with the rates of using BP-lowering, glucose-lowering, lipid-lowering, and aspirin being 37.7% (95% CI, 32.8%–42.8%), 41.4% (95% CI, 35.8%–47.3%), 6.7% (95% CI, 4.5%–10.0%), and 1.0% (95% CI, 0.6%–1.8%), respectively. As for risk factor control, only 29.3% (95% CI, 25.7%–33.2%), 16.8% (95% CI, 15.0%–18.6%), and 36.0% (95% CI, 31.1%–41.2%) of individuals with high ASCVD risk had ideal levels of blood pressure, LDL-C, and body weight.ConclusionThe estimated prevalence of 10-year high ASCVD risk was high in Guangzhou, while the rates of treatment and risk factor control in primary prevention were still far from optimal, especially for lipid management. These findings suggested that substantial improvement in ASCVD prevention is needed in this population. |
| first_indexed | 2024-03-12T23:38:36Z |
| format | Article |
| id | doaj.art-43f4d533fc0d4a019c29bcc3281e5cb2 |
| institution | Directory Open Access Journal |
| issn | 2297-055X |
| language | English |
| last_indexed | 2024-03-12T23:38:36Z |
| publishDate | 2023-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj.art-43f4d533fc0d4a019c29bcc3281e5cb22023-07-15T03:19:14ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-07-011010.3389/fcvm.2023.10920581092058Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, ChinaHui Liu0Weiquan Lin1Weiquan Lin2Kexin Tu3Qin Zhou4Qin Zhou5Chang Wang6Minying Sun7Minying Sun8Yaohui Li9Xiangyi Liu10Guozhen Lin11Sidong Li12Wei Bao13Department of Basic Public Health, Center for Disease Control and Prevention of Guangzhou, Guangzhou, ChinaDepartment of Basic Public Health, Center for Disease Control and Prevention of Guangzhou, Guangzhou, ChinaInstitute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, ChinaDepartment of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, ChinaDepartment of Basic Public Health, Center for Disease Control and Prevention of Guangzhou, Guangzhou, ChinaInstitute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, ChinaDepartment of Basic Public Health, Center for Disease Control and Prevention of Guangzhou, Guangzhou, ChinaDepartment of Basic Public Health, Center for Disease Control and Prevention of Guangzhou, Guangzhou, ChinaInstitute of Public Health, Guangzhou Medical University & Guangzhou Center for Disease Control and Prevention, Guangzhou, ChinaDepartment of Basic Public Health, Center for Disease Control and Prevention of Guangzhou, Guangzhou, ChinaDepartment of Basic Public Health, Center for Disease Control and Prevention of Guangzhou, Guangzhou, ChinaDepartment of Basic Public Health, Center for Disease Control and Prevention of Guangzhou, Guangzhou, ChinaInstitute of Public Health Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, ChinaInstitute of Public Health Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, ChinaBackgroundIdentifying individuals at high risk of atherosclerotic cardiovascular disease (ASCVD) and implementing targeted prevention strategies might be the key to reducing the heavy disease burden in China. This study aimed to evaluate the prevalence, awareness, treatment, and risk factor control among individuals with high 10-year ASCVD risk in Guangzhou, China.MethodsThis study included 15,165 adults (aged 18 years and older) from 138 urban and rural communities in the 2018 survey of China Chronic Disease and Risk Factors Surveillance in Guangzhou. 10-year ASCVD risk was estimated using the risk assessment models recommended in the Chinese Guideline for the Prevention of Cardiovascular Disease 2017. The prevalence, awareness, treatment, and risk factor control of high ASCVD risk (defined as 10-year risk ≥10%) were examined.ResultsAmong the study population, the weighted proportion of men was 51.9%, and the mean age was 41.27 ± 0.52 years. The overall standardized prevalence of high 10-year ASCVD risk was 13.8% (95% CI, 12.4%–15.3%). The awareness rates for hypertension, diabetes, and hyperlipidemia were 48.0% (95% CI, 42.8%–53.4%), 48.3% (95% CI, 43.0%–53.7%), and 17.9% (95% CI, 14.4%–22.1%) among those with corresponding risk factors. The proportions of drug use in prevention were relatively low in primary prevention, with the rates of using BP-lowering, glucose-lowering, lipid-lowering, and aspirin being 37.7% (95% CI, 32.8%–42.8%), 41.4% (95% CI, 35.8%–47.3%), 6.7% (95% CI, 4.5%–10.0%), and 1.0% (95% CI, 0.6%–1.8%), respectively. As for risk factor control, only 29.3% (95% CI, 25.7%–33.2%), 16.8% (95% CI, 15.0%–18.6%), and 36.0% (95% CI, 31.1%–41.2%) of individuals with high ASCVD risk had ideal levels of blood pressure, LDL-C, and body weight.ConclusionThe estimated prevalence of 10-year high ASCVD risk was high in Guangzhou, while the rates of treatment and risk factor control in primary prevention were still far from optimal, especially for lipid management. These findings suggested that substantial improvement in ASCVD prevention is needed in this population.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1092058/fullcardiovascular riskprevalenceawarenesstreatmentGuangzhourisk assessment & management |
| spellingShingle | Hui Liu Weiquan Lin Weiquan Lin Kexin Tu Qin Zhou Qin Zhou Chang Wang Minying Sun Minying Sun Yaohui Li Xiangyi Liu Guozhen Lin Sidong Li Wei Bao Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China Frontiers in Cardiovascular Medicine cardiovascular risk prevalence awareness treatment Guangzhou risk assessment & management |
| title | Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China |
| title_full | Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China |
| title_fullStr | Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China |
| title_full_unstemmed | Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China |
| title_short | Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China |
| title_sort | prevalence awareness treatment and risk factor control of high atherosclerotic cardiovascular disease risk in guangzhou china |
| topic | cardiovascular risk prevalence awareness treatment Guangzhou risk assessment & management |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1092058/full |
| work_keys_str_mv | AT huiliu prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT weiquanlin prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT weiquanlin prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT kexintu prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT qinzhou prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT qinzhou prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT changwang prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT minyingsun prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT minyingsun prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT yaohuili prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT xiangyiliu prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT guozhenlin prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT sidongli prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina AT weibao prevalenceawarenesstreatmentandriskfactorcontrolofhighatheroscleroticcardiovasculardiseaseriskinguangzhouchina |